Join our ELEVATE Clinical Study today. Sign-up now

Type-1 Interferon Test for Lupus

image8
Fingerstick Blood Collection  hads
Blood Collection Tube icon46

IFN-1

Type-1 Interferon Test for Lupus

Type-1 Interferon (IFN-1) activity is an essential component in your patients’ immune response to infection; however, persistently high IFN-1 activity has been shown to play a central role in the development of Systemic Lupus Erythematosus (SLE) disease and progression. An estimated 50% of SLE patients overexpress IFN-1 and disease severity correlates with expression level. Overexpression of IFN-1 has been shown to lead to an increased risk for disease complications and progression to Lupus Nephritis. DxTerity’s IFN-1 Test is designed to measure IFN-1 activity prior to starting therapy and to monitor IFN-1 levels in response to therapy.
 
 
Learn more
image8
Fingerstick Blood Collection  hads
Blood Collection Tube icon46
image9
Fingerstick Blood Collection  hads

COVID-19

Neutralizing Antibody Test for autoimmune patients

Individual immune systems may respond differently to COVID-19 infection and vaccination. Most individuals will generate a high level of protective COVID-19 neutralizing antibodies following vaccination or infection, but those with weakened immune systems may fail to generate an adequate response. Patients with common autoimmune diseases like lupus, rheumatoid arthritis, and multiple sclerosis, and patients on immunosuppressive therapies may be at risk of an impaired immune response and therefore, may benefit by taking extra precautions to avoid infection. A simple, accurate and reliable test to measure a patient’s COVID-19 neutralizing antibody levels may provide information regarding the response to vaccination, booster, or prior infection.
 
 
Learn more
image67
Saliva Collection hads

COVID-19

COVID-19 PCR Test

DxTerity's SARS-CoV-2 RT-PCR saliva-based test is FDA EUA authorized for at-home sample collection. Simply collect your patient's sample and ship it to our lab for testing. Using state-of-the-art PCR technology, DxTerity tests your patient's sample for the presence of the virus. You will be notified when the results are available through our secure portal.
 
Submission #: EUA202120
Granted by FDA: 8/28/2020
Device: DxTerity SARS-CoV-2 RT-PCR CE Test
 
 
Learn more
image67
Saliva Collection hads

 

Better health management begins
at home

Subscribe to receive the latest information on new developments and products at DxTerity.